Company News
| Oct 5, 2011 |
Baeta Corp. and Advanced Scientific Marketing to Introduce
MyHealthTrends |
| Sept 26, 2011 |
Baeta Corp. and Welch & Associates to Introduce MyHealthTrends |
| Aug 26, 2011 |
Baeta Corp. Engages Imagine Growth Strategy, Inc. as Business Advisor |
| June 13, 2011 |
Interview Highlights Baeta Corp.'s Leading Edge Healthcare Solutions |
| May 16, 2011 |
Baeta Corp. Initiates Clinical Trial at NYU School of Medicine |
| May 4, 2011 |
Baeta Corp. Expands Market Awareness Programs |
| Apr 7, 2011 |
Baeta Corp. Receives Clearance From DTCC |
| Mar 30, 2011 |
Baeta Corp. Receives Funding From an Institutional Investor |
| Feb 23, 2011 |
Baeta Corp. Introduces MyHealthTrends for Pain |
| Feb 10, 2011 |
Baeta Corp. Advances to Next Level, Files S-1 Registration Statement |
| Jan 18, 2011 |
Baeta Corp. Chosen as Best Stock Pick of the Year |
| Dec 22, 2010 |
One-Third of Americans Dieted in 2010: Cravings a Major Factor |
| Oct 5, 2010 |
Baeta Corp. Announces MyHealthTrends for Weight Control, Version 2.0 |
| June 30, 2010 |
Baeta Corp. Registration Statement Approved by the United States SEC |
| Apr 7, 2010 |
Baeta Corp. Launches of MyHealthTrends for Weight Control |
| Sept 21, 2009 |
Baeta Corp. Presents MyHealthTrends for Pain at PAINWeek 2009 |
| July 14, 2009 |
Baeta Corp. Announces Formation of Management Team |
| Feb 9, 2009 |
Baeta Corp. Announces the Formation of Scientific Advisory Board |
| Jan 12, 2009 |
Baeta Corp. Accepts Invitation to Integrate Products into Be-Alive |
| Dec 29, 2008 |
Baeta Corp. Announces the Availability of MyPainAway |
| Dec 22, 2008 |
Baeta Corp. Files an S-1/A with the SEC |
| Oct 14, 2008 |
Baeta Corp. Files S-1 with the Securities and Exchange Commission |
| Sept 16, 2008 |
Baeta Corp. Acquires MyHealthID |
BAETA Corp. and Advanced Scientific Marketing to Introduce MyHealthTrends to Northern California
FORT LEE, N.J., Oct. 5, 2011 (GLOBE NEWSWIRE) -- BAETA Corp. (OTCBB:BAEA.OB - News), an advanced technology-enabled health improvement company headquartered in Fort Lee, New Jersey, announced today a marketing arrangement whereby the Company intends to work with Advanced Scientific Marketing to introduce the MyHealthTrends&tm; product suite to physicians and healthcare professionals in northern California.
"Given the number of pain professionals within the region, we are delighted to work with a firm possessing regional expertise and ready access to our target market," said Len Pushkantser, Chief Executive Officer of BAETA Corp. "We are thrilled to work with Advanced Scientific Marketing to bring MyHealthTrends to specialized practices within northern California," said Mr. Pushkantser.
"MyHealthTrends is a breakthrough solution uniquely enabling patients and practitioners to effectively capture, quantify, and treat pain like never before," said Khristopher Karambela of Advanced Scientific Marketing. "We are particularly excited about the ability of MyHealthTrends to provide a remote, 24/7 window into patient pain levels enabling the physician to proactively contact the patient and modify treatment regimens with confidence," said Karambela.
Contact
For more information about BAETA Corp., please visit http://www.baetacorp.com/
Mr. Leonid Pushkantser
Chief Executive Officer, BAETA Corp.
1 Bridge Plaza Suite 275
Fort Lee, NJ 07024
(201) 471-0988, Extension 106
lenpu@baetacorp.com
About BAETA Corp.
BAETA Corp. (OTCBB:BAEA.OB - News) is a technology-enabled health improvement company whose objective is to empower patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. BAETA Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data. Please visit BAETA Corp. at http://www.baetacorp.com for more information about our products.
Not a Broker/Dealer or Financial Advisor
BAETA Corp. is not a Registered Broker/Dealer or a Financial Advisor, nor does it hold itself out to be a Registered Broker/Dealer or Financial Advisor. All material presented in this press release, on the Company's website or other media is not to be regarded as investment advice and is only for informative purposes. Readers should verify all claims and conduct their own due diligence before investing in BAETA Corp. Investing in small-cap, micro cap and penny stock securities is speculative and carries a high degree of risk.
No Offer of Securities
None of the information featured in this press release constitutes an offer or solicitation to purchase or to sell any securities of BAETA Corp.
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS
Information presented in this press release contains "forward looking statements" within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements." Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects," "foresee," "expects," "will," "anticipates," "estimates," "believes," "understands," or that by statements indicating certain actions "may," "could," or "might" occur. Understand there is no guarantee past performance will be indicative of future results.
None of the information contained on the BAETA Corp. website is incorporated by reference herein.
BAETA Corp. and Welch & Associates to Introduce MyHealthTrends to the Southeastern United States
FORT LEE, NJ--(PRNewswire – 09/26/11) - BAETA Corp. (OTCBB: BAEA.OB - News), an advanced technology-enabled health improvement company headquartered in Fort Lee, New Jersey, announced today a marketing arrangement whereby the Company intends to work with Welch & Associates of Atlanta, Georgia to introduce the MyHealthTrends™ product suite to physicians and healthcare professionals in the southeast region.
"We are delighted to work with Welch & Associates given their experience introducing and selling medical products to doctors, medical practices, and specialty healthcare professionals," stated Len Pushkantser, Chief Executive Officer of BAETA Corp. "We are confident Welch & Associates will help to enhance the awareness and sales of MyHealthTrends throughout selected states within the southeast," said Mr. Pushkantser.
"Given the unique benefits and value proposition associated with MyHealthTrends for Pain and MyHealthTrends for Weight Control, we are excited to help practitioners elevate their standard of care," said Carl Welch, President of Welch & Associates. "Of particular importance is the availability of CPT codes facilitating reimbursement for these innovative products. And given the growing number of individuals impacted by pain and overweight conditions, the potential for these products is substantial," said Welch.
Contact
For more information about BAETA Corp., please visit http://www.baetacorp.com/ or contact:
Mr. Leonid Pushkantser
Chief Executive Officer, BAETA Corp.
1 Bridge Plaza Suite 275
Fort Lee, NJ 07024
(201) 471-0988, Extension 106
lenpu@baetacorp.com
About BAETA Corp.
BAETA Corp. (OTCBB: BAEA - News) is a technology-enabled health improvement company whose objective is to empower patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. BAETA Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data. Please visit BAETA Corp. at http://www.baetacorp.com for more information about our products.
Not a Broker/Dealer or Financial Advisor
BAETA Corp. is not a Registered Broker/Dealer or a Financial Advisor, nor does it hold itself out to be a Registered Broker/Dealer or Financial Advisor. All material presented in this press release, on the Company's website or other media is not to be regarded as investment advice and is only for informative purposes. Readers should verify all claims and conduct their own due diligence before investing in BAETA Corp. Investing in small-cap, micro cap and penny stock securities is speculative and carries a high degree of risk.
No Offer of Securities
None of the information featured in this press release constitutes an offer or solicitation to purchase or to sell any securities of BAETA Corp.
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS
Information presented in this press release contains "forward looking statements" within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements." Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects," "foresee," "expects," "will," "anticipates," "estimates," "believes," "understands," or that by statements indicating certain actions "may," "could," or "might" occur. Understand there is no guarantee past performance will be indicative of future results.
None of the information contained on the BAETA Corp. website is incorporated by reference herein.
BAETA Corp. Engages Imagine Growth Strategy, Inc. as Business Advisory Consultant
FORT LEE, NJ--(PRNewswire – 08/26/11) - BAETA Corp. (OTCBB: BAEA.OB) - News), an advanced technology-enabled health improvement company located in Fort Lee, New Jersey, announced today that it has engaged Imagine Growth Strategy, Inc. to assist the Company as a business advisory consultant. Imagine Growth Strategy will help the Company to target an array of potentially beneficial financial transactions, including the targeting of potential mergers and acquisitions, and to further facilitate growth with respect to the Company’s business development. A Current Report on Form 8-K describing the transaction has been filed with the Securities and Exchange Commission on August 25, 2011.
"We welcome the opportunity to work with the Imagine Growth Strategy as we seek to introduce exciting and revolutionary new approaches for healthcare management to the marketplace," stated Len Pushkantser, Chief Executive Officer of BAETA Corp. "We are pleased to have a partner that recognizes the value of fact-based data that helps lead to faster diagnoses, improved treatment via remote monitoring, and improved patient health," said Mr. Pushkantser.
"We are delighted to partner with BAETA Corp. to help usher in the era of participatory healthcare led by BAETA’s MyHealthTrends product suite," said Alan D. Lewis II, Managing Partner of Imagine Growth Strategy, Los Angeles.
"We are excited about the large and growing markets served by BAETA Corp. well as the technical and health-related expertise within BAETA Corp. We believe investors, once aware of the Company and its offerings, will share precisely the same sentiment," said Ryan Dean Hoggan, Managing Partner of Imagine Growth Strategy, Salt Lake City.
Contacts:
For more information about Baeta Corp., please visit http://www.baetacorp.com/ or contact:
For BAETA Corp:
Mr. Leonid Pushkantser
Chief Executive Officer, BAETA Corp.
1 Bridge Plaza Suite 275
Fort Lee, NJ 07024
(201) 471-0988, Extension 106
lenpu@baetacorp.com
For Imagine Growth Strategy:
Mr. Alan D. Lewis II
Managing Partner, Imagine Growth Strategy, Los Angeles
(661) 600-6140
About BAETA Corp.
BAETA Corp. (OTCBB: BAEA - News) is a technology-enabled health improvement company whose objective is to empower patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. BAETA Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data. Please visit BAETA Corp. at http://www.baetacorp.com for more information about our products.
Not a Broker/Dealer or Financial Advisor
BAETA Corp. is not a Registered Broker/Dealer or a Financial Advisor, nor does it hold itself out to be a Registered Broker/Dealer or Financial Advisor. All material presented in this press release, on the Company's website or other media is not to be regarded as investment advice and is only for informative purposes. Readers should verify all claims and conduct their own due diligence before investing in BAETA Corp. Investing in small-cap, micro cap and penny stock securities is speculative and carries a high degree of risk.
No Offer of Securities
None of the information featured in this press release constitutes an offer or solicitation to purchase or to sell any securities of BAETA Corp.
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS
Information presented in this press release contains "forward looking statements" within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements." Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects," "foresee," "expects," "will," "anticipates," "estimates," "believes," "understands," or that by statements indicating certain actions "may," "could," or "might" occur. Understand there is no guarantee past performance will be indicative of future results.
None of the information contained on the BAETA Corp. website is incorporated by reference herein.
BAETA Corp. Subject of New Interview Highlighting the Company's Leading Edge Healthcare Solutions
FORT LEE, N.J., June 13, 2011 /PRNewswire/ --- BAETA Corp. (OTCBB:BAEA.ob - News), a New Jersey corporation and provider of technology-enabled health improvement products, today announced the online availability of an interview with the Company's Chief Marketing Officer, Lee Smith, sharing information regarding the Company's products, markets, and business strategy. The interview can be found on the internet at:
http://www.baetacorp.com/content/LasVegasBAEA.mp3
BAETA Corp. and its flagship product, MyHealthTrends, empowers practitioners to uniquely leverage new forms of patient data to improve patient health. Available as MyHealthTrends for Pain and MyHealthTrends for Weight Control, the products accurately quantify sensations experienced by patients without the need for diaries, smart phones, or memory-based recall. 
"By enabling patients to click the "Pain" or "Crave" Button, pain sensations and food cravings are easily captured in a portable device the size of a modern automobile key. The data is uploaded, analyzed by patent-pending algorithms, and used to generate graphs available via the Internet for the patient and the doctor," said Lee Smith, Chief Marketing Officer of BAETA Corp.
MyHealthTrends targets key market segments including:
- Partners that recommend, require, or resell the product such as physicians, pharmaceutical firms and insurance companies.
- Consumers who purchase MyHealthTrends directly and use it to better document and understand their own pain, cravings, and body.
- Clinical environments such hospitals and healthcare facilities where MyHealthTrends is available via a prescription.
"With an increasing focus on preventative medicine, heightening care quality, and bending the cost curve, the timing for BAETA and MyHealthTrends is ideal. And with the recent identification of applicable CPT codes combined with the potential to address large and growing markets, we sense the pieces are coming together nicely," said Smith.
For additional information regarding BAETA Corp., its business model, the execution of its strategy, please contact:
Mr. Leonid Pushkantser
Chief Executive Officer
1 Bridge Plaza Suite 275
Fort Lee, NJ 07024
(201) 471-0988, Extension 106
About BAETA Corp.:
BAETA Corp. (OTCBB:BAEA.OB.ob - News) is a technology-enabled health improvement company whose objective is to empower patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. BAETA Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data.
No Offer of Securities:
None of the information featured in this press release constitutes/ an offer or solicitation to purchase or to sell any securities of BAETA Corp.
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS:
Information presented in this press release contains "forward looking statements" within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects," "foresee," "expects," "will," "anticipates," "estimates," "believes," "understands," or that by statements indicating certain actions "may," "could," or "might" occur. Understand there is no guarantee past performance will be indicative of future results.
Baeta Corp. Initiates Clinical Trial at NYU School of Medicine to Measure Efficacy of Pain Recording Device
Fort Lee, NJ--(Marketwire - 05/16/11) - NYU School of Medicine will conduct a clinical trial to measure the efficacy of Baeta Corp.'s MyHealthTrends for Pain handheld device during intra-operative, pre- and post-surgical periods. This trial will compare the current standard of pain care monitoring to Baeta’s device which facilitates accurate data collection.
Michael Haile, MD and director of Clinical Research at NYU School of Medicine will oversee the initiative as the Principal Investigator. "We are interested in the practical application of a portable, handheld device for patients to quantify pain and the ability to translate this information into enhanced treatment regimens and outcomes relative to the current standard of pain care monitoring," said Dr. Haile.
The protocol has been reviewed and approved by NYU School of Medicine's Institutional Review Board (IRB).
We look forward to the opportunity to determine if the standard of pain care monitoring can be advanced using this technology," said Dr. Alexander Gak, Chairman of Baeta Corp. "With limited tools to quantify pain, this is an important initiative for any individual suffering from acute or chronic pain," said Gak.
Upon conclusion of the clinical trial Baeta intends to apply for a CPT reimbursement code. "This is an important step for Baeta Corp.'s commercialization of its advanced patient care products," stated Len Pushkantser, CEO of Baeta Corp. Physicians, hospitals, and other health care providers use CPT codes to report medical services to private and public health insurance systems for purposes of reimbursement.
For additional information, please contact:
Mr. Leonid Pushkantser
Chief Executive Officer
1 Bridge Plaza Suite 275
Fort Lee, NJ 07024
(201) 471-0988, Extension 106
About Baeta Corp.:
Baeta Corp. (OTC.BB:BAEA - News) is a technology-enabled health improvement company whose objective is to empower patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. Baeta Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data. Please visit Baeta Corp. at http://www.baetacorp.com/ for more information about our products.
Not a Broker/Dealer or Financial Advisor:
Baeta Corp. is not a Registered Broker/Dealer or a Financial Advisor, nor does it hold itself out to be a Registered Broker/Dealer or Financial Advisor. All material presented in this press release, on the Company's website or other media is not to be regarded as investment advice and is only for informative purposes. Readers should verify all claims and conduct their own due diligence before investing in Baeta Corp. Investing in small-cap, micro cap and penny stock securities is speculative and carries a high degree of risk.
No Offer of Securities:
None of the information featured in this press release constitutes an offer or solicitation to purchase or to sell any securities of Baeta Corp.
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS:
Information presented in this press release contains "forward looking statements" within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects," "foresee," "expects," "will," "anticipates," "estimates," "believes," "understands," or that by statements indicating certain actions "may," "could," or "might" occur. Understand there is no guarantee past performance will be indicative of future results.
None of the information contained on the Baeta Corp. website is incorporated by reference herein.
Baeta Corp. Expands Market Awareness Programs
Fort Lee, NJ--(Marketwire - 05/04/11) - Baeta Corp. (OTCBB: BAEA.OB) a New Jersey corporation and provider of technology-enabled health improvement products, today announced that it has commenced expanding its market awareness program by partnering with StockVest, a company dedicated to showcasing emerging growth investment opportunities. In addition to featuring Baeta Corp. on premier internet destinations for investors seeking information on emerging growth stocks, StockVest will also help disseminate Baeta Corp's press releases to a much wider audience within the investment community. StockVest's market awareness program is focused on assisting its featured public companies attain maximum market awareness with the investment community, in efforts to increase trading volume, broaden shareholder bases, and in efforts to attain increased share valuations.
As part of this initiative, StockVest will present Baeta Corp. at the 2011 Las Vegas Money show. The Las Vegas Money Show will be held at the prestigious Caesars Palace Resort and Conference Center from the 9th to 12th of May 2011, on the world famous Las Vegas Strip. Attendees from around the globe will be presented with a wealth of Baeta Corp. information and a good understanding of the future direction of the Company.
I look forward to working with StockVest as they increase our exposure within the investment community, and the launch of Baeta Corp.'s new approach for investor relations services," stated Len Pushkantser, CEO of Baeta Corp. "As part of our new Investor Relations program, StockVest has joined our investor relations team and will be representing Baeta Corp. at various expos to showcase our business plan."
The Money Show spearheaded the field of investment trade shows over 30 years ago with the concept of inviting select individual investors, expert speakers, select exhibitors, and select investment media partners to gather together in a live forum where their interaction creates a dynamic marketplace. The Money Show is produced annually in Las Vegas, San Francisco, Orlando, Chicago, London, Toronto, and Vancouver with special focuses for each venue.
Additional information regarding Baeta Corp. can also be found online at http://www.baetacorp.com/.
For additional information, please contact:
Mr. Leonid Pushkantser
Chief Executive Officer
1 Bridge Plaza Suite 275
Fort Lee, NJ 07024
(201) 471-0988, Extension 106
About Baeta Corp.:
Baeta Corp. (OTC.BB:BAEA - News) is a technology-enabled health improvement company whose objective is to empower patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. Baeta Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data. Please visit Baeta Corp. at http://www.baetacorp.com/ for more information about our products.
Not a Broker/Dealer or Financial Advisor:
Baeta Corp. is not a Registered Broker/Dealer or a Financial Advisor, nor does it hold itself out to be a Registered Broker/Dealer or Financial Advisor. All material presented in this press release, on the Company's website or other media is not to be regarded as investment advice and is only for informative purposes. Readers should verify all claims and conduct their own due diligence before investing in Baeta Corp. Investing in small-cap, micro cap and penny stock securities is speculative and carries a high degree of risk.
No Offer of Securities:
None of the information featured in this press release constitutes an offer or solicitation to purchase or to sell any securities of Baeta Corp.
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS:
Information presented in this press release contains "forward looking statements" within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects," "foresee," "expects," "will," "anticipates," "estimates," "believes," "understands," or that by statements indicating certain actions "may," "could," or "might" occur. Understand there is no guarantee past performance will be indicative of future results.
None of the information contained on the Baeta Corp. website is incorporated by reference herein.
BAETA Corp. Receives Clearance From the Depository Trust & Clearing Corporation
FORT LEE, NJ--(Marketwire - 04/07/11) - BAETA Corp. (OTC.BB:BAEA - News), a New Jersey corporation and provider of technology-enabled health improvement products, announces that it has received clearance on April 4, 2011 from the Depository Trust & Clearing Corporation (DTCC), allowing for efficient clearing and settlement of transactions involving sales of BAETA Corp. common stock.
"BAETA Corp. has satisfied all of the requirements of DTCC enabling investors, broker/dealers, and other market participants to buy and sell shares and settle transactions in an extremely efficient and streamlined manner, further enhancing the potential for liquidity of our Common Stock," stated Mr. Len Pushkantser, Chief Executive Officer of BAETA Corp. "We are pleased BAETA Corp. has joined the prestigious list of DTCC authorized and eligible securities."
"With the DTCC functioning as the central custodian for more than 3.6 million securities valued at almost $34 trillion in 2009, shares of BAETA Corp. are now DTC-eligible -- providing buyers and sellers with an efficient mechanism to clear and settle transactions," said Mr. Yonah Kopstick, Vice President at Worldwide Stock Transfer, LLC., BAETA Corp.'s transfer agent of record.
Additional information regarding BAETA Corp. can also be found online at http://www.baetacorp.com/.
Contacts and Additional Information
For additional information, please contact:
Mr. Leonid Pushkantser
Chief Executive Officer
1 Bridge Plaza Suite 275
Fort Lee, NJ 07024
(201) 471-0988, Extension 106
About BAETA Corp.:
BAETA Corp. (OTC.BB:BAEA - News) is a technology-enabled health improvement company whose objective is to empower patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. BAETA Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data. Please visit BAETA Corp. at http://www.baetacorp.com/ for more information about our products.
Not a Broker/Dealer or Financial Advisor:
BAETA Corp. is not a Registered Broker/Dealer or a Financial Advisor, nor does it hold itself out to be a Registered Broker/Dealer or Financial Advisor. All material presented in this press release, on the Company's website or other media is not to be regarded as investment advice and is only for informative purposes. Readers should verify all claims and conduct their own due diligence before investing in BAETA Corp. Investing in small-cap, micro cap and penny stock securities is speculative and carries a high degree of risk.
No Offer of Securities:
None of the information featured in this press release constitutes an offer or solicitation to purchase or to sell any securities of BAETA Corp.
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS:
Information presented in this press release contains "forward looking statements" within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects," "foresee," "expects," "will," "anticipates," "estimates," "believes," "understands," or that by statements indicating certain actions "may," "could," or "might" occur. Understand there is no guarantee past performance will be indicative of future results.
None of the information contained on the BAETA Corp. website is incorporated by reference herein.
Baeta Corp. Receives Funding From an Institutional Investor
FORT LEE, NJ--(Marketwire – 03/29/11) - Baeta Corp. (OTCBB: BAEA.OB), an advanced technology-enabled health improvement company located in Fort Lee, New Jersey, announced today that it has received an investment from an Accredited institutional Investor. A Current Report on Form 8-K describing the transaction has been filed with the Securities and Exchange Commission on March 29, 2011.
For more information about Baeta Corp., please visit http://www.baetacorp.com/ or contact:
Mr. Leonid Pushkantser, CEO
Baeta Corp.
1.201.471.0988 X106
About Baeta Corp.
Baeta Corp. (OTC.BB:BAEA - News) is a technology-enabled health improvement company whose objective is to empower patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. Baeta Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data. Please visit Baeta Corp. at http://www.baetacorp.com/ for more information about our products.
Not a Broker/Dealer or Financial Advisor
Baeta Corp. is not a Registered Broker/Dealer or a Financial Advisor, nor does it hold itself out to be a Registered Broker/Dealer or Financial Advisor. All material presented in this press release, on the Company's website or other media is not to be regarded as investment advice and is only for informative purposes. Readers should verify all claims and conduct their own due diligence before investing in Baeta Corp. Investing in small-cap, micro cap and penny stock securities is speculative and carries a high degree of risk.
No Offer of Securities
None of the information featured in this press release constitutes an offer or solicitation to purchase or to sell any securities of Baeta Corp.
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS
Information presented in this press release contains "forward looking statements" within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements." Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects," "foresee," "expects," "will," "anticipates," "estimates," "believes," "understands," or that by statements indicating certain actions "may," "could," or "might" occur. Understand there is no guarantee past performance will be indicative of future results.
None of the information contained on the Baeta Corp. website is incorporated by reference herein.
Baeta Corp. Introduces MyHealthTrends for Pain
New Approach to Recording Pain Empowers Patients and Enhances Physician Understanding
FORT LEE, NJ--(Marketwire - 02/23/11) - BAETA Corp. (OTC.BB:BAEA - News), an advanced technology-enabled health improvement company, announces the availability of MyHealthTrends™ for Pain -- a breakthrough solution to help patients record their pain. 
Developed by a physician, MyHealthTrends for Pain replaces traditional paper-based diaries and patient recall with a portable, easy to use "Pain Button" that is carried and depressed by the patient whenever they experience pain.
By connecting the "Pain Button" to their computer, the time stamped pain data is securely retrieved. MyHealthTrends for Pain then displays intuitive charts, patent-pending pain scores, and diagnostic data for the patient and authorized healthcare professionals via the Internet.
"By pressing the Pain Button, patients easily document their pain whenever it occurs -- converting complaints into actionable, quantifiable data for their physician leading to improved treatment and faster pain relief," said Dr. Alexander Gak, Chairman of BAETA Corp.
Physicians benefit from MyHealthTrends for Pain by:
- Acquiring data that more accurately reflects the pain experienced by their patients
- Remotely monitoring patient pain levels via the Internet
- Treating patients with confidence while reducing the potential risk of addiction and legal complications often associated with over-prescribing
"Based upon the findings presented at PAINWeek 2009, physicians using MyHealthTrends for Pain easily identified pain patterns and altered medication schedules to reduce patient pain levels," said Gak.
MyHealthTrends for Pain is ideal for those with:
- Fibromyalgia / Arthritis
- Migraines / Headaches
- Back Pain / Herniated Disk / Sciatica / Neck or Knee Pain
- Cancer / Lupus
- Depression / Anxiety
- Pre / Intra / Post Operative Conditions
"With chronic pain affecting one out of every four Americans with a direct cost of $50 Billion annually, we are eager to help reduce the impact of pain as the leading cause of disability in the United States," stated Len Pushkantser, Chief Executive Officer of BAETA Corp. "We are excited about the ability to help countless pain sufferers and usher in a new era of participatory healthcare," said Pushkantser.
MyHealthTrends for Pain was developed with the oversight and guidance of BAETA Corp.'s Scientific Advisory Board that includes: Alex Y. Bekker, M. D., Ph. D., Marco Pappagallo, M.D., Samyadev Datta, M.B., B.S., FRCA, and Lauren Shaiova, M.D., B.S.
For more information, please visit the MyHealthTrends for Pain product website
About Baeta Corp.
BAETA Corp. (OTC.BB:BAEA - News) is a technology-enabled health improvement company whose objective is to empower patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. BAETA Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data. Please visit BAETA Corp. at http://www.baetacorp.com for more information about our products.
Not a Broker/Dealer or Financial Advisor
BAETA Corp. is not a Registered Broker/Dealer or a Financial Advisor, nor does it hold itself out to be a Registered Broker/Dealer or Financial Advisor. All material presented in this press release, on the Company's website or other media is not to be regarded as investment advice and is only for informative purposes. Readers should verify all claims and conduct their own due diligence before investing in BAETA Corp. Investing in small-cap, micro cap and penny stock securities is speculative and carries a high degree of risk.
No Offer of Securities
None of the information featured in this press release constitutes an offer or solicitation to purchase or to sell any securities of BAETA Corp.
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS
Information presented in this press release contains "forward looking statements" within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements." Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects," "foresee," "expects," "will," "anticipates," "estimates," "believes," "understands," or that by statements indicating certain actions "may," "could," or "might" occur. Understand there is no guarantee past performance will be indicative of future results.
None of the information contained on the BAETA Corp. website is incorporated by reference herein.
Baeta Corp. Advances to Next Level, Files S-1 Registration Statement
FORT LEE, NJ -- (Marketwire - 02/10/11) - Baeta Corp. (OTC.BB:BAEA - News), an advanced provider of technology-enabled health improvement solutions, filed a Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed offering of the Company's common stock. The Company filed the registration statement on Friday, February 4, 2011.
A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time that the registration statement becomes effective. This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities described above, nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
A portion of the shares being registered are being offered for sale pursuant to a Reserve Equity Financing Agreement entered into between the Company and AGS Capital Group, LLC on September 28, 2010, as previously reported in a Current Report on Form 8-K filed with the SEC on October 5, 2010. The remaining shares will be offered to the public through Baeta's Officers and Directors on a best-efforts basis.
"We are pleased to access the capital markets directly, efficiently raising funds to support the growth of Baeta Corp. and our flagship product suite, MyHealthTrends™," stated Len Pushkantser, Chief Executive Officer of Baeta Corp. "We are particularly excited about the prospect of accelerating the growth of Baeta Corp. and driving the sale and use of our health-focused products," concluded Pushkantser.
For additional information, please contact Len Pushkantser, CEO of Baeta Corp., at (201) 471-0988, extension 106. About Baeta Corp.
Baeta Corp. (OTC.BB:BAEA - News) is a technology-enabled health improvement company whose objective is to empower patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. Baeta Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data. Please visit Baeta Corp. at http://www.baetacorp.com/ for more information about our products. Not a Broker/Dealer or Financial Advisor
Baeta Corp. is not a Registered Broker/Dealer or a Financial Advisor, nor does it hold itself out to be a Registered Broker/Dealer or Financial Advisor. All material presented in this press release, on the Company's website or other media is not to be regarded as investment advice and is only for informative purposes. Readers should verify all claims and conduct their own due diligence before investing in Baeta Corp. Investing in small-cap, micro cap and penny stock securities is speculative and carries a high degree of risk. No Offer of Securities
None of the information featured in this press release constitutes an offer or solicitation to purchase or to sell any securities of Baeta Corp. SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS
Information presented in this press release contains "forward looking statements" within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements." Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects," "foresee," "expects," "will," "anticipates," "estimates," "believes," "understands," or that by statements indicating certain actions "may," "could," or "might" occur. Understand there is no guarantee past performance will be indicative of future results.
None of the information contained on the Baeta Corp. website is incorporated by reference herein.
Baeta Corp. Chosen as Best Stock Pick of the Year by Prominent Hedge Fund
FORT LEE, N.J.--(BUSINESS WIRE)-- Baeta Corp. (OTCBB:BAEA.ob - News) announced today that they have been chosen as the best stock pick for 2011 by the prestigious hedge fund, InterMarket Edge, Inc. "We are absolutely thrilled that InterMarket Edge has chosen us as their number one stock pick for 2011," stated Len Pushkantser, CEO of Baeta Corp. "As our technology continues to emerge throughout the medical community, physicians and healthcare professionals continue to rave about the effectiveness of our targeted pain management, weight control, and smoking cessation products and the benefit that they’ve experienced with their patients."
"I am a strong proponent of Wall Street saying that it is not worth knowing what everybody knows. In order to succeed in trading and investments one has to find companies that are positioned for success by having exceptional products at the right time, and finding those companies before everyone else does," stated Dennis V. Leontyev, President of InterMarket Edge, Inc. "Currently I'm worried about the speculative coloration on the rise in stock prices globally since the conclusion of March 2009. I do not think the markets will continue rising as they have since then. My bias has again shifted temporarily to the bearish side, which makes me cautious about picking stocks in early 2011. With that caveat in mind, I am staying away from well known names, which are correlated to the stock market indexes, which in turn makes it even more sense than ever to look for ‘Diamonds in the Rough’."
"Considering all of the above, my pick for 2011 is Baeta Corp. Baeta Corp., a technology-enabled health improvement company, engages in empowering patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. The Company develops healthcare information solutions for use by patients and healthcare professionals. The company’s flagship product, MyHealthTrends for Pain, is a pain management and assessment product targeted for chronic pain sufferers in the United States. They also offer MyHealthTrends for Weight Control to assist in weight loss and control; and MyHealthTrends for Smoking Cessation to help customers quit smoking. In addition, the company provides MyPillsOnTime, an automatic medication reminder/dispenser system for consumer market," continued Leontyev.
"In my opinion this stock represents the most lucrative opportunity for 2011. Baeta Corp is a speculative, low price issue, which went public just a few months ago. The company didn’t use investment banking syndicates in order to be listed, which means that financial institutions are not invested in it just yet. This means that if the big boys – such as the hedge funds and small cap mutual funds get involved, demand is likely to quickly exceed supply by a huge margin. Share prices do not usually wait for numbers to come through before they move higher. They move higher in anticipation of better earnings ahead. This should happen after the company reports numbers for the first and second quarter of next year.
"So, how do we know that this company is going to succeed? First, the growth opportunities in the health care industry are obvious. The growing numbers of elderly, and the need for less expensive health care including pain management, will likely create industry growth of 15% to 20% during the next several years and decades. Second, the company is positioned to benefit from the US healthcare dollars shifting towards preventive care, as well as new regulations calling for zero dollars out of pocket for weight control and smoking cessation-related doctor visits. Third, the management of Baeta Corp. is extremely impressive, which makes me feel much more confident in investing in the stock. Fourth, the company’s debt is miniscule compared to industry average and earnings potential."
Baeta Corp is currently trading at $1.16 per share with a market capitalization of $27.5M. "Projected 2011 revenues should justify a stock price up to $3 to $4 per share. We are looking at up to 300% return on investment with relatively low risk and no correlation to the stock market. This represents one of those rare opportunities to get in a stock way ahead of institutions.
"If you have a shopping list for 2011, Baeta Corp should definitely be on that list. I always look for the gift that keeps on giving; that's how I view Baeta Corp., which should produce a steady stream of income each and every quarter," concluded Leontyev.
About Baeta Corp.
Baeta Corp. (OTCBB:BAEA.OB - News) is a technology-enabled health improvement company empowering patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. Baeta Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data. Please visit Baeta Corp. at http://www.baetacorp.com
Safe Harbor & Disclaimer
Statements pertaining to a company's future value and growth potential are considered "forward-looking" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995. Baeta Corp. intends that such statements and all forward-looking statements be subject to the safe harbors created thereby. Actual results may differ significantly from those expressed or implied. Information has been carefully compiled from sources deemed to be reliable, but accuracy is not guaranteed. Investing in securities is speculative and carries a high degree of risk. All information should be independently verified. Investors need to perform their own due diligence with any investment decision to fully understand all risks. This release has been prepared by Baeta Corp. and should not be constituted in any way as an offer to sell or acquire any securities. For additional information, please contact Baeta Corp. at 201.471.0988.
One-Third of Americans Dieted in 2010
Cravings most frequently cited as a factor impacting diets
Fort Lee, NJ (PRWEB) December 22, 2010 -- A recent survey of 500 Americans conducted for Baeta Corp. (OTCBB: BAEA.OB) reveals that nearly one in five (21%) Americans are currently on a diet, with another 13% abandoning their weight control efforts in 2010. Surprisingly, 21% also believe they should be on a diet -- but are not.
 |
"These numbers reflect the expanding need and market for weight control services and solutions," said Len Pushkantser, CEO of Baeta Corp. "As waist lines continue to grow, new approaches are required to help dieters be successful -- and we are fully committed to identifying and removing roadblocks for them," said Pushkantser. |
81% of survey participants stated their diets would be more successful if they could manage their food cravings as they occur Given abandonment rates, the survey also reveals food cravings are most frequently cited as a factor that impacts a diet. The list includes:
In fact, 81% of survey participants stated their diets would be more successful if they could manage their food cravings as they occur.
|
"This is precisely why we created MyHealthTrends for Weight Control -- a hand-held solution empowering dieters to easily record their cravings in real-time, acting as a behavioral circuit breaker," said Pushkantser.
"With nearly two-thirds of all current, former, and potential dieters willing to share their craving data with their doctor, dietitian, nutritionist, or family member, increased accountability holds the potential to dramatically increase success rates," said Pushkantser.
The online survey acquired 500 completions from a representative sample of Americans and was conducted on December 21, 2010 by Toluna, a leading global market research firm. In aggregate, the data possess a tolerance of +/- 4.4% at the 95% confidence level. |
 |
To learn more about the research, please contact:
Lee Smith, Chief Marketing Officer
201.471.0988 X103
lee_smith(at)baetacorp(dot)com
About Baeta Corp.
Baeta Corp. (OTCBB: BAEA.OB) is a technology-enabled health improvement company empowering patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. Baeta Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data. Please visit Baeta Corp. at http://www.baetacorp.com/
Safe Harbor & Disclaimer:
Statements pertaining to a company's future value and growth potential are considered "forward-looking" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995. Baeta Corp. intends that such statements and all forward-looking statements be subject to the safe harbors created thereby. Actual results may differ significantly from those expressed or implied. Information has been carefully compiled from sources deemed to be reliable, but accuracy is not guaranteed. Investing in securities is speculative and carries a high degree of risk. All information should be independently verified. Investors need to perform their own due diligence with any investment decision to fully understand all risks. This release has been prepared by Baeta Corp. and should not be constituted in any way as an offer to sell or acquire any securities. For additional information, please contact Baeta Corp. at 201.471.0988.
Baeta Corp. Announces the Availability of MyHealthTrends for Weight Control, Version 2.0 
New version incorporates significant ease of use and new Patient management capabilities for Practitioners--facilitating weight control and behavior modification.
Fort Lee, NJ, October 5, 2010 --(PR.com)--Baeta Corp. (OTCBB: BAEA.OB), a provider of technology-enabled health improvement solutions, has released version 2.0 of MyHealthTrends for Weight Control.
The single interface, enhanced solution enables users to more easily upload, analyze, and interpret their food cravings and compliance via the Internet.
"Demonstrating our ongoing commitment to our customers, we have made it even easier for users of all ages--from teens to seniors--to alter their eating behaviors using accurate, non-recall craving and compliance data," said Len Pushkantser, CEO of Baeta Corp.
The latest version also provides additional capabilities for Practitioners, including, among others, the ability to:
"With nearly half of all Americans classified as obese or overweight, we are pleased to provide the only dedicated handheld device to record cravings -- helping to modify eating behaviors through clear craving and compliance reporting," said Dr. Alexander Gak, Chairman of Baeta Corp.
More Information:
To learn more about MyHealthTrends for Weight Control, please visit http://weightcontrol.myhealthtrends.com or contact:
Sales Department
201.471.0988 X105
sales@baetacorp.com
About Baeta Corp.:
Baeta Corp. (OTCBB: BAEA.OB) is a technology-enabled health improvement company empowering patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. Baeta Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data. Please visit Baeta Corp. at http://www.baetacorp.com/
Safe Harbor & Disclaimer:
Statements pertaining to a company's future value and growth potential are considered "forward-looking" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995. Baeta Corp. intends that such statements and all forward-looking statements be subject to the safe harbors created thereby. Actual results may differ significantly from those expressed or implied. Information has been carefully compiled from sources deemed to be reliable, but accuracy is not guaranteed. Investing in securities is speculative and carries a high degree of risk. All information should be independently verified. Investors need to perform their own due diligence with any investment decision to fully understand all risks. This release has been prepared by Baeta Corp. and should not be constituted in any way as an offer to sell or acquire any securities. For additional information, please contact Baeta Corp. at 201.471.0988.
Baeta Corp. Registration Statement Approved by the United States Securities and Exchange Commission
Common Stock of Baeta Corp. to trade under the symbol BAEA.OB
Baeta Corp. is pleased to announce it has completed a Registration Statement with the United States Securities and Exchange Commission effective May 14, 2010.
Under the Registration Statement, investors will in the near future be able to buy and sell shares of Baeta Corp. common stock via the OTC Bulletin Board (OTCBB) using the stock symbol, BAEA.OB.
“As we continue to expand the offerings of Baeta Corp, we are delighted to enable additional investors to partake in the participatory healthcare model—empowering patients to actively elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses,” said Dr. Alexander Gak, Baeta Corp. Chairman and President.
“Our revolutionary MyHealthTrends product suite was designed by a physician to be patient-friendly, uniquely capture and report high fidelity data, and address patient ailments across many large and growing sectors—starting with weight control and pain management,” said Len Pushkantser, Chief Executive Officer of Baeta Corp.
This announcement is neither an offer to sell nor a solicitation of an offer to buy any shares of common stock, warrants or other securities of Baeta Corp. No offer, solicitation or sale will be made in any jurisdiction in which such offer, solicitation or sale is unlawful.
More Information
For additional information please contact:
Len Pushkantser
Chief Executive Officer
201.471.0988 X106
ir@baetacorp.com
About Baeta Corp.
Baeta Corp. is a technology-enabled health improvement company empowering patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. Baeta Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data. Please visit us at http://www.baetacorp.com/
Safe Harbor & Disclaimer
Statements pertaining to a company's future value and growth potential are considered "forward-looking" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995. Baeta Corp. intends that such statements and all forward-looking statements be subject to the safe harbors created thereby. Actual results may differ significantly from those expressed or implied. Information has been carefully compiled from sources deemed to be reliable, but accuracy is not guaranteed. Investing in securities is speculative and carries a high degree of risk. All information should be independently verified. Investors need to perform their own due diligence with any investment decision to fully understand all risks. This release has been prepared by Baeta Corp. and should not be constituted in any way as an offer to sell or acquire any securities. For additional information, please contact Baeta Corp. at 201.471.0988.
Baeta Corp. Launches of MyHealthTrends for Weight Control to Help Drive Behavior Modification
Innovative solution empowers patients to record and view their food cravings -- adding a critical dimension to weight control regimens facilitating behavior modification.
Fort Lee, NJ, April 07, 2010 --(PR.com)-- Baeta Corp. announces the availability of MyHealthTrends for Weight Control -- enabling Registered Dietitians, Nutritionists, Weight Counselors, Physicians, and related Healthcare Professionals to help their patients record and gain control of their food cravings -- facilitating behavior modification and sustainable weight loss. 
MyHealthTrends combines handheld device technology, computer software, and the Internet to easily allow patients to record their food cravings whenever and wherever they occur. A small, handheld portable device allows patients to record their cravings and responses as directed by their healthcare professional.
By connecting the handheld "Crave Button" to their computer, data is securely downloaded and MyHealthTrends produces charts, compliance metrics, and diagnostic reports for the patient and authorized healthcare professionals via the Internet.
"Our objective is to easily empower patients to monitor their own cravings, create a level of self awareness and accountability, and facilitate behavior modification at the direction of healthcare professionals," said Leonid Pushkantser, CEO of Baeta Corp. "MyHealthTrends is among the industry's first steps in this important direction," said Pushkantser.
MyHealthTrends for Weight Control is a vital tool for patients and healthcare professionals providing:
- Accurate, non-recall based craving data -- overcoming the patient challenges of written diaries.
- A customizable behavior modification program -- allowing healthcare professionals to specify prescribed craving responses and diagnostic data to be provided by the patient.
- Remote, online access to a patient's performance -- providing powerful and easy to interpret charts even between visits.
- An essential complement to traditional calorie counting and food frequency tools -- providing a more complete patient view.
"MyHealthTrends for Weight Control is the first in a series of technology-driven healthcare solutions empowering patients and healthcare professionals to measure and improve treatment," said Dr. Alexander Gak, Founder and Chairman of Baeta Corp. "We are excited to usher in a new era of truly participatory healthcare," said Gak.
More Information
To learn more about MyHealthTrends for Weight Control, please visit http://weightcontrol.myhealthtrends.com or contact:
Sales Department
201.471.0988 X105
sales@baetacorp.com
About Baeta Corp
Baeta Corp. is a technology-enabled health improvement company empowering patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. Baeta Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data. Please visit them at http://www.baetacorp.com.
Safe Harbor & Disclaimer
Statements pertaining to a company's future value and growth potential are considered "forward-looking" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995. Baeta Corp. intends that such statements and all forward-looking statements be subject to the safe harbors created thereby. Actual results may differ significantly from those expressed or implied. Information has been carefully compiled from sources deemed to be reliable, but accuracy is not guaranteed. Investing in securities is speculative and carries a high degree of risk. All information should be independently verified. Investors need to perform their own due diligence with any investment decision to fully understand all risks. This release has been prepared by Baeta Corp. and should not be constituted in any way as an offer to sell or acquire any securities. For additional information, please contact Baeta Corp. at 201.471.0988.
Baeta Corp. Presents Abstract of MyHealthTrends for Pain at PAINWeek 2009 Conference
MyHealthTrends for Pain ushers in a new era of portable, patient-centric pain recording devices.
Las Vegas, NV, September 11, 2009 — The findings of a study reviewing the efficacy of MyHealthTrends for Pain as a quantitative pain monitoring solution were presented at the PAINWeek 2009 Conference by Dr. Michael Semenovski and Dr. Marco Pappagallo.
The study entitled "Miniature Electronic Diary Device for Patient Based Registration of Pain Sensation at Minute Intervals with Internet Communicability" consisted of multiple patients, each with chronic pain. The research reveals the simplicity of the portable, handheld MyHealthTrends device improves pain recording compliance compared to traditional recall-based paper diary approaches and more elaborate screen-based electronic diary systems.
"We are delighted to share the findings conducted by an esteemed team of professionals including: Dr. Alex Bekker, Dr. Marco Pappagallo, Dr. Samyadev Datta, and Dr. Lauren Shaiova, Dr. Richard Kline, Dr. Michael Semenovski, and Dr. Leonid Topper," said Len Pushkantser, CEO of Baeta Corp. "We are particularly excited about the opportunity to dramatically improve the accuracy and ease of pain reporting using MyHealthTrends’ patient-centric, user friendly device—which we believe will directly lead to improved patient treatment and care," said Mr. Pushkantser.
To view images and a brief video from the PAINWeek 2009 Conference, please visit: http://www.baetacorp.com/news_PAINWeek_2009.aspx
About Baeta Corp.
Baeta Corp. is a technology-enabled health improvement company empowering patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. Baeta Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data.
More Information:
Len Pushkantser, Chief Executive Officer
201.471.0988
info@baetacorp.com
Safe Harbor & Disclaimer:
Statements pertaining to a company's future value and growth potential are considered "forward-looking" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995. Baeta Corp. intends that such statements and all forward-looking statements be subject to the safe harbors created thereby. Actual results may differ significantly from those expressed or implied. Information has been carefully compiled from sources deemed to be reliable, but accuracy is not guaranteed. Investing in securities is speculative and carries a high degree of risk. All information should be independently verified. Investors need to perform their own due diligence with any investment decision to fully understand all risks. This release has been prepared by Baeta Corp. and should not be constituted in any way as an offer to sell or acquire any securities. For additional information, please contact Baeta Corp. at 201.471.0988.
BAETA Corp. Announces Formation of Management Team
BAETA Corp. announced today the formation of its management team responsible for the daily operation of the company.
"I am personally and professionally delighted to welcome such a team of seasoned and uniquely qualified individuals to BAETA Corp," said Dr. Alexander Gak, BAETA Corp. Chairman. "Each member of the management team brings exceptional skills and expertise across a multitude of functional areas. Working together, I look forward to rapidly accelerating the growth of BAETA Corp." said Gak.
Members of the management team include:
Len Pushkantser, Chief Executive Officer
Working in the manufacturing and medical industries for more than two decades, Mr. Pushkantser has proven experience manufacturing and bringing new products to market -- both domestically and internationally. Mr. Pushkantser's skills and experiences have been an essential ingredient in driving continuous growth.
Prior to joining Baeta Corp., Mr. Pushkantser was the Vice President of Operations for AFC Industries where he was responsible for engineering, manufacturing, quality assurance, customer service, human resources, cost accounting and profitability, and compliance with FDA, EPA, and OSHA standards. Previously, Mr. Pushkantser was also a Director of Manufacturing, Plant Manager and Processing Manager for an FDA regulated automated cancer screening test.
Mr. Pushkantser received a Master's of Science in Business Operations and a Bachelor's of Science in Mechanical Engineering -- both from Polytechnic University in Kiev, Ukraine.
Jeff Burkland, Chief Financial Officer
Mr. Burkland has over 15 years of strategic and tactical financial management experience. Adept in business plan development, process improvement, SOX compliance, and pre-public company financing, Mr. Burkland has shaped and managed the financial function for numerous companies including those in the technology and manufacturing industries.
Previously Mr. Burkland was the Vice President of Finance and Operations for Synaptex, a software company focused upon information management. As a member of the senior management team, Mr. Burkland developed the business plan and forecasts for the company. Mr. Burkland also worked for UTStarcom, Zhone Technologies, NorthPoint Communications, and AT&T where he developed and implemented plans to penetrate new markets, capture market share, and increase margins.
Mr. Burkland received an MBA from the Harvard Business School and a Bachelor's of Science in Electrical Engineering and Economics from Duke University -- Summa Cum Laude.
Eugene Gribov, Chief Technology Officer
Mr. Gribov has more than 20 years of international engineering management, product development, and offshore manufacturing management experience across a wide array of sectors including the Information Technology and Medical industries.
Mr. Gribov is the President of Globe Audio Design Inc. which develops high-power audio solutions. Previously Mr. Gribov designed semiconductor, integrated circuitry, optoelectronic, and software-based solutions for Kintek Inc. and Globe Ltd. Further showcasing Mr. Gribov's technical skills, he worked in a select group of researchers under the direct supervision of Nobel Prize winner, Zhores Alferov.
Mr. Gribov graduated with honors from Sankt-Peterburgskij Gosudarstvennyj Elektrotehniceskij Universitet (LETI) with a Master's of Science in Electrical Engineering.
Lee Smith, Chief Marketing Officer
With more than 20 years of experience in the technology, marketing, and advertising industries, Mr. Smith has a demonstrated track record of developing new products, defining successful brands, creating marketplace awareness, and driving sales.
Mr. Smith is the President and CEO of Persuasive Brands, a marketing services agency dedicated to branding and sales generation. Previously, Mr. Smith was the founder, COO, and acting CEO of InsightExpress, a firm he grew to one of the 50 largest market research companies in the United States in six years. Mr. Smith's innovative ideas and business practices have been recognized via four U.S. patents.
Mr. Smith holds an MBA in Marketing and Finance from Carnegie Mellon University's Tepper Business School and a Bachelor's of Science in Computer Science from The Pennsylvania State University.
Leonid Topper, M.D., Chief Medical Officer
Dr. Topper is a Board Certified Neurologist with a specialty in Pediatric Neurology. Currently an Attending Neurologist with Pediatric Neurology Associates, Dr. Topper has extensive experience in the diagnosis and management of patients with seizures, epilepsy, headaches, brain infections, stroke, tics and Tourette syndrome, nerve and muscle conditions, autistic disorders, ADHD, and neonatal brain problems.
Previously, Dr. Topper was an Attending Pediatric Neurologist at Schneider Children's Hospital and an Attending Pediatric Neurologist at Chaim Sheba Medical Center in Israel.
An internationally distinguished lecturer and prolific author, Dr. Topper is an Examiner for The American Board of Psychiatry and Neurology. Dr. Topper is also a member of The Royal College of Pediatrics and Child Health in the United Kingdom.
Dr. Topper received his Doctor of Medicine Degree from Kaunas Medical Academy in Kaunas, Lithuania conducted his internship at Vilnius Children's Hospital in Vilnius, Lithuania.
To view this information online with accompanying photographs, please visit: http://www.baetacorp.com/COMPANY_Management.aspx
About BAETA Corp.
BAETA Corp. is a technology-enabled health improvement company empowering patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. BAETA Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data.
More Information:
Dr. Alexander Gak, Chairman
Len Pushkantser, Chief Executive Officer
201.849.4555
info@baetacorp.com
Safe Harbor & Disclaimer:
Statements pertaining to a company's future value and growth potential are considered "forward-looking" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995. BAETA Corp. intends that such statements and all forward-looking statements be subject to the safe harbors created thereby. Actual results may differ significantly from those expressed or implied. Information has been carefully compiled from sources deemed to be reliable, but accuracy is not guaranteed. Investing in securities is speculative and carries a high degree of risk. All information should be independently verified. Investors need to perform their own due diligence with any investment decision to fully understand all risks. This release has been prepared by BAETA Corp. and should not be constituted in any way as an offer to sell or acquire any securities. For additional information, please contact BAETA Corp. at 201.849.4555.
BAETA Corp. Announces the Formation of Scientific Advisory Board
Members are renowned, world-class doctors specializing in pain management
BAETA Corp. announced today the formation of its Scientific Advisory Board to oversee in-hospital usage of BAETA offerings and to help shape the company’s future product portfolio.
"We are delighted to have an Advisory Board composed of such esteemed and accomplished medical professionals," said Dr. Alexander Gak, BAETA Corp. Chairman and CEO. "Each member brings decades of experience advancing the understanding and treatment of pain—fundamentally improving the lives of patients. We look forward to the contributions and expertise of these uniquely qualified healthcare innovators and practitioners." said Gak.
The members of the BAETA Corp. Scientific Advisory Board include:
Alex Y. Bekker, M. D., Ph. D.
Professor of Anesthesiology and Neurosurgery and Vice Chair for Research at NYU School of Medicine in New York; Attending Anesthesiologist, New York University Medical Center and Bellevue Hospital in New York. Dr. Bekker is Chairman of the Scientific Advisory Board for BAETA Corp.
Dr. Bekker earned his Ph.D. in Biomedical Engineering from the New Jersey Institute of Technology in Newark and his M.D. from University of Medicine and Dentistry of New Jersey. Completing his residency in anesthesiology at Columbia-Presbyterian Medical Center in New York, Dr. Bekker has a longstanding interest in the perioperative management of geriatric patients. Dr. Bekker has served as the principal investigator of numerous clinical trials related to perioperative care of the elderly, treatment of acute pain and postoperative nausea and vomiting, and clinical pharmacology of new analgesics and sedatives. The author of more than 50 original papers in peer-reviewed journals, Dr. Bekker is regularly invited to present lectures and moderate scientific panels at the most prestigious national and international anesthesiology/pain management meetings. Dr. Bekker is internationally recognized as an expert in clinical pharmacology, neuroanesthesia, postoperative pain management and perioperative organ protection.
Click to view the detailed resume of Dr. Bekker.
Marco Pappagallo, M.D.
Professor, Department of Anesthesiology and Director of Pain Medicine Research and Development at the Mount Sinai School of Medicine in New York, New York.
Dr. Pappagallo is one of the foremost experts in the field of pain medicine. Since mid-2006, Dr. Pappagallo has served as a Professor in the Department of Anesthesiology at Mount Sinai School of Medicine in New York City, where he is also an Director of Pain Medicine Research and Development and Attending Physician.
In the past, Dr. Pappagallo held the titles of Director-Division of Chronic Pain and Attending Physician in the Department of Pain Medicine and Palliative Care at Beth Israel Medical Center in New York City, and prior to this, Director of the Comprehensive Pain Treatment Center and Attending Physician in the Department of Neurology at the Hospital for Joint Diseases, in New York City. He also served as an Attending Physician in the Department of Neurology and Director, Division of Pain Medicine (Department of Neurology) at The Johns Hopkins Medical Institutions in Baltimore. Dr Pappagallo has also served as an Associate Professor in the departments of Neurology and Anesthesiology at Albert Einstein College of Medicine and the NYU School of Medicine, both in New York.
Click to view the detailed resume of Dr. Pappagallo.
Samyadev Datta, M.B., B.S., FRCA.
Director, Center for Pain Management in Hackensack, New Jersey.
Dr. Datta earned his medical degree from the Government Medical College in Mysore, India. Board Certified in anesthesiology from three countries, Dr. Datta conducted his most recent postdoctoral training in anesthesiology and pain management at Columbia Presbyterian Medical Center, Memorial Sloan-Kettering Cancer Center, and Cornell University Medical College, all in New York, New York.
An author of numerous articles, contributor to multiple books, and frequent guest speaker, Dr. Datta is a member of the Association of Anaesthetists of Great Britain and Ireland, American Society of Anesthesiology, International Association for the Study of Pain, International Spinal Intervention Society, and American Society of Interventional Pain Physicians. As a nationally recognized expert in pain management, Dr. Datta has served on the Advisory Boards of Faulding Laboratories and Janssen Pharmaceuticals, among others. He is presently involved in multiple drug trials.
Click to view the detailed resume of Dr. Datta.
About BAETA Corp.
BAETA Corp. develops and manufactures consumer medical products intended to address Chronic Pain Management and Vital Signs Monitoring markets. BAETA Corp's first product, MyPainAway, is currently being manufactured and available for sale to consumers.
More Information:
Dr. Alexander Gak, President & CEO
Douglas A Rogers, Interim CFO
(201) 471-0998
info@baetacorp.com
Safe Harbor & Disclaimer:
Statements pertaining to a company's future value and growth potential are considered "forward-looking" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995. BAETA Corp. intends that such statements and all forward-looking statements be subject to the safe harbors created thereby. Actual results may differ significantly from those expressed or implied. Information has been carefully compiled from sources deemed to be reliable, but accuracy is not guaranteed. Investing in securities is speculative and carries a high degree of risk. All information should be independently verified. Investors need to perform their own due diligence with any investment decision to fully understand all risks. This release has been prepared by BAETA Corp. and should not be constituted in any way as an offer to sell or acquire any securities. For additional information, please contact BAETA Corp. at (210) 471-0998.
BAETA Corp. Accepts Invitation to Integrate Its Online Products within the Be-Alive Portal
MyPainAway is the first of the BAETA Corp. products available via www.Be-Alive.org
BAETA Corp., an innovative provider of technology-driven healthcare information solutions enabling patients to easily capture vital data to help medical professionals measure and improve treatment, announces it has been invited by Extranome, Inc. to include its online products within the www.Be-Alive.org Portal.
"We are delighted to join www.Be-Alive.org to provide easy, seamless access to MyPainAway for all of our current and future customers," said Dr. Alexander Gak, Chairman and CEO of BAETA Corp. "We view the BeAlive Portal as the next generation vehicle enabling consumers, patients, and medical professionals to obtain integrated access to both public and personal information. We look forward to making MyHealthID and future BAETA Corp. offerings available via the BeAlive Portal," said Gak.
The BeAlive Portal, www.Be-Alive.org, is an integrated, secure online solution providing easy access to personal online products, public Internet content, and email. BeAlive helps individual consumers easily acquire the information of interest to them while helping online enterprises experience heightened activity levels and revenue.
About BAETA Corp.
BAETA Corp. develops and manufactures consumer medical products intended to address Chronic Pain Management and Vital Signs Monitoring markets. BAETA Corp's first product, MyPainAway, is currently being manufactured and available for sale to consumers.
More Information:
Dr. Alexander Gak, President & CEO
Douglas A Rogers, Interim CFO
(201) 471-0998
info@baetacorp.com
Safe Harbor & Disclaimer:
Statements pertaining to a company's future value and growth potential are considered "forward-looking" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995. BAETA Corp. intends that such statements and all forward-looking statements be subject to the safe harbors created thereby. Actual results may differ significantly from those expressed or implied. Information has been carefully compiled from sources deemed to be reliable, but accuracy is not guaranteed. Investing in securities is speculative and carries a high degree of risk. All information should be independently verified. Investors need to perform their own due diligence with any investment decision to fully understand all risks. This releease has been prepared by BAETA Corp. and should not be constituted in any way as an offer to sell or acquire any securities. For additional information, please contact BAETA Corp. at (210) 471-0998.
BAETA Corp. Announces the Availability of MyPainAway
MyPainAway ushers in a new era empowering individuals to record and help contribute to the pain management process
BAETA Corp. announces today the availability of MyPainAway, a pioneering pain recording and reporting solution for those afflicted with pain.
Developed by a medical doctor to help those afflicted by pain associated with Fibromyalgia, Arthritis, Cancer Lupus, Migraines and headaches, Depression, Sciatica, Herniated Discs, injuries, or other sources, MyPainAway easily enables individuals to record their sensations - helping them to work in concert with their medical professionals to acquire faster and superior diagnoses and treatment.
"We are delighted to usher in a new era empowering individuals to record and actively participate in the management and treatment of chronic and acute pain," said Dr. Alexander Gak, Chairman and CEO of BAETA Corp. "The World Health Organization (WHO) states the ability to live without pain is now a fundamental, inalienable human right and we believe MyPainAway is a landmark solution providing unparalleled benefits for patients and medical practitioners directly in line with the WHO's position on pain," said Gak.
MyPainAway combines the latest hand-held device, computer software, and Internet technology empowering individuals to record their pain whenever and wherever it occurs. Using a computer or access to the Internet, patients can view and share graphical representations of their pain - indicating frequency, intensity, and other metrics over time.
To learn more about MyPainAway, please visit our product website, www.mypainaway.com. MyPainAway is also available for purchase.
About BAETA Corp.
BAETA Corp. develops and manufactures consumer medical products intended to address Chronic Pain Management and Vital Signs Monitoring markets. BAETA Corp's first product, MyPainAway, is currently being manufactured and expected to be available for sale to consumers during the fourth quarter of 2008.
More Information:
Dr. Alexander Gak, President & CEO
Douglas A Rogers, Interim CFO
(201) 471-0998
info@baetacorp.com
Safe Harbor & Disclaimer:
Statements pertaining to a company's future value and growth potential are considered "forward-looking" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995. BAETA Corp. intends that such statements and all forward-looking statements be subject to the safe harbors created thereby. Actual results may differ significantly from those expressed or implied. Information has been carefully compiled from sources deemed to be reliable, but accuracy is not guaranteed. Investing in securities is speculative and carries a high degree of risk. All information should be independently verified. Investors need to perform their own due diligence with any investment decision to fully understand all risks. This releease has been prepared by BAETA Corp. and should not be constituted in any way as an offer to sell or acquire any securities. For additional information, please contact BAETA Corp. at (210) 471-0998.
BAETA Corp. Responds to SEC Comments and Files an S-1/A
Responding to comments received from the Securities and Exchange Commission and as part of the filing process, BAETA Corp. has filed an S-1/A with the SEC.
The S-1/A is available online from the Securities and Exchange Commission at: http://idea.sec.gov/Archives/edgar/data/1439636/000114420408070662/v135482_s1a.htm
About BAETA Corp.
BAETA Corp. develops and manufactures consumer medical products intended to address Chronic Pain Management and Vital Signs Monitoring markets. BAETA Corp's first product, MyPainAway, is currently being manufactured and expected to be available for sale to consumers during the fourth quarter of 2008.
More Information:
Dr. Alexander Gak, President & CEO
Douglas A Rogers, Interim CFO
(201) 471-0998
info@baetacorp.com
Safe Harbor & Disclaimer:
Statements pertaining to a company's future value and growth potential are considered "forward-looking" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995. BAETA Corp. intends that such statements and all forward-looking statements be subject to the safe harbors created thereby. Actual results may differ significantly from those expressed or implied. Information has been carefully compiled from sources deemed to be reliable, but accuracy is not guaranteed. Investing in securities is speculative and carries a high degree of risk. All information should be independently verified. Investors need to perform their own due diligence with any investment decision to fully understand all risks. This releease has been prepared by BAETA Corp. and should not be constituted in any way as an offer to sell or acquire any securities. For additional information, please contact BAETA Corp. at (210) 471-0998.
BAETA Corp. Files S-1 with the Securities and Exchange Commission
BAETA Corp. offers 946,680 common shares via the secondary, public market
BAETA Corp. announced today that it has filed its Prospectus Statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") to sell approximately 946,680 common shares in the secondary, or public market. BAETA Corp. is registering for re-sale, shares acquired privately by a number of individual shareholders in a recent private offering of common stock completed by BAETA Corp. BAETA Corp. is also registering a number of shares held by various service providers that have accepted equity-in-lieu payments for services rendered during BAETA Corp.'s commercial development.
Upon being deemed effective by the SEC, the shares registered will become available for re-sale in the public markets, by those individuals and corporations included in the registration statement. BAETA Corp. anticipates that, when it achieves this milestone, its shares will trade in the U.S. Over The Counter ("OTC") market.
For more information, or to view BAETA Corp.'s prospectus in its entirety, please see: http://www.sec.gov/Archives/edgar/data/1439636/000114420408057575/v128818_s1.htm
About BAETA Corp.
BAETA Corp. develops and manufactures consumer medical products intended to address Chronic Pain Management and Vital Signs Monitoring markets. BAETA Corp's first product, MyPainAway, is currently being manufactured and expected to be available for sale to consumers during the fourth quarter of 2008.
More Information:
Dr. Alexander Gak, President & CEO
Douglas A Rogers, Interim CFO
(201) 471-0998
info@baetacorp.com
Safe Harbor & Disclaimer:
Statements pertaining to a company's future value and growth potential are considered "forward-looking" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995. BAETA Corp. intends that such statements and all forward-looking statements be subject to the safe harbors created thereby. Actual results may differ significantly from those expressed or implied. Information has been carefully compiled from sources deemed to be reliable, but accuracy is not guaranteed. Investing in securities is speculative and carries a high degree of risk. All information should be independently verified. Investors need to perform their own due diligence with any investment decision to fully understand all risks. This releease has been prepared by BAETA Corp. and should not be constituted in any way as an offer to sell or acquire any securities. For additional information, please contact BAETA Corp. at (210) 471-0998.
BAETA Corp. Acquires MyHealthID
Acquisition further positions BAETA Corp. to be a preeminent infrastructure provider for the Healthcare Industry.
BAETA Corp. announced today the acquisition of MyHealthID Online Medical Record Systems from Extranome, Inc, a privately-held Internet Content Management company.
"MyHealthID was created by harnessing the distributed, ubiquitous, and easy-to-use capabilities of the Internet with the benefits of banking-grade security and regulatory compliance. MyHealthID offers unparalleled flexibility in communication and document exchange between patients and healthcare providers within a secure, HIPAA-compliant environment,: said Dr. Gak, Chairman and CEO of BAETA Corp.
The addition of MyHealthID to the growing portfolio of BAETA products will further enable BAETA Corp. to become an infrastructure and solution provider for the $2 trillion Healthcare Sector.
"We plan to fully leverage and expand the capabilities of MyHealthID by linking a personal device to the existing BAETA Corp. Internet-based application. This solution will perfectly complement the line of handheld devices BAETA is already producing and facilitate a seamless integration of MyHealthID functionality to other BAETA products," said Gak.
Additional details regarding the transaction can be obtained by contacting BAETA Corp. at ir@baetacorp.com.
Copyright © 2011 Baeta Corp. All rights reserved.
|
